Filings under SPRO by SmartPros Ltd. (CIK 0001289863) from May 13, 2008 to Mar 5, 2015 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Zack Debra | Chief Medical Officer | Grant(A) | 162K | — | $0 |
| Aug 3, 2026 | Zack Debra | Chief Medical Officer | Grant(A) | 325K | — | $0 |
| Jun 23, 2026 | Deshpande Milind | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Jackson Scott Thomas | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Smith Cynthia | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Thomas Frank E | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Vink Patrick V.J.J. | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Tregoning Kathleen | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Pottage John C Jr | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| May 4, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 25K | $2.51 | $63K |
| Feb 6, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 19K | $2.36 | $44K |
| Feb 6, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 37K | $2.36 | $88K |
| Feb 6, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 51K | $2.36 | $120K |
| Feb 4, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 3K | $2.24 | $8K |
| Feb 3, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 24K | $2.14 | $52K |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 18K | $2.20 | $41K |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Grant(A) | 249K | — | $0 |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Grant(A) | 498K | — | $0 |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 19K | $2.20 | $42K |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 68K | — | $0 |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 137K | — | $0 |
| Nov 7, 2025 | Rajavelu Esther | See Remarks | Sell(S) | 40K | $2.37 | $95K |
| Aug 28, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 2K | $1.97 | $3K |
| Aug 28, 2025 | Mahadevia Ankit | Director | Sell(S) | 7K | $1.97 | $13K |
| Jun 12, 2025 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| May 2, 2025 | Rajavelu Esther | See Remarks | Grant(A) | 185K | — | $0 |
| Feb 5, 2025 | Mahadevia Ankit | Director | Sell(S) | 14K | $0.78 | $11K |
| Feb 5, 2025 | Mahadevia Ankit | Director | Sell(S) | 55K | $0.78 | $43K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 106K | $0.78 | $83K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 43K | $0.78 | $33K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 6K | $0.78 | $5K |
| Feb 5, 2025 | Rajavelu Esther | CFO & CBO | Sell(S) | 21K | $0.78 | $16K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 25K | $0.78 | $19K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 28K | $0.78 | $22K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 4K | $0.78 | $3K |
| Feb 3, 2025 | Shukla Sath | CEO & President | Grant(A) | 751K | — | $0 |
| Feb 3, 2025 | Rajavelu Esther | CFO & CBO | Grant(A) | 100K | — | $0 |
| Feb 3, 2025 | Rajavelu Esther | CFO & CBO | Grant(A) | 266K | — | $0 |
| Feb 3, 2025 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 266K | — | $0 |
| Nov 8, 2024 | Rajavelu Esther | CFO & CBO | Sell(S) | 17K | $1.30 | $22K |
| Nov 7, 2024 | Rajavelu Esther | CFO & CBO | Sell(S) | 23K | $1.31 | $31K |
| Aug 27, 2024 | Shukla Sath | CEO & President | Sell(S) | 3K | $1.35 | $4K |
| Aug 27, 2024 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 2K | $1.35 | $3K |
| Aug 27, 2024 | Mahadevia Ankit | Director | Sell(S) | 6K | $1.35 | $8K |
| Aug 5, 2024 | Shukla Sath | CEO and President | Sell(S) | 18K | $1.31 | $23K |
| Aug 2, 2024 | Shukla Sath | CEO and President | Sell(S) | 15K | $1.32 | $20K |
| May 29, 2024 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Feb 5, 2024 | Shukla Sath | CEO and President, Director | Sell(S) | 45K | $1.45 | $65K |
| Feb 2, 2024 | Shukla Sath | CEO and President, Director | Sell(S) | 31K | $1.37 | $42K |
| Feb 2, 2024 | Hamed Kamal | Chief Medical Officer | Sell(S) | 28K | $1.37 | $38K |
| Feb 2, 2024 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 31K | $1.37 | $42K |
| Feb 2, 2024 | Mahadevia Ankit | Director | Sell(S) | 64K | $1.37 | $87K |
| Feb 2, 2024 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 31K | $1.36 | $42K |
| Feb 1, 2024 | Shukla Sath | CEO and President, Director | Grant(A) | 680K | — | $0 |
| Feb 1, 2024 | Rajavelu Esther | See Remarks | Grant(A) | 120K | — | $0 |
| Feb 1, 2024 | Hamed Kamal | Chief Medical Officer | Grant(A) | 240K | — | $0 |
| Feb 1, 2024 | Joseph Tamara L | Chief Legal Officer | Grant(A) | 240K | — | $0 |
| Feb 1, 2024 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2024 | Tregoning Kathleen | Director | Grant(A) | 36K | $1.12 | $40K |
| Nov 13, 2023 | Rajavelu Esther | See Remarks | Grant(A) | 300K | — | $0 |
| Oct 5, 2023 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| Sep 13, 2023 | Hamed Kamal | Chief Medical Officer | Sell(S) | 39K | $1.27 | $50K |
| Aug 29, 2023 | Shukla Sath | CEO and President, Director | Sell(S) | 4K | $1.30 | $5K |
| Aug 28, 2023 | Shukla Sath | CEO and President, Director | Sell(S) | 2K | $1.26 | $2K |
| Aug 28, 2023 | Mahadevia Ankit | Director | Sell(S) | 9K | $1.26 | $11K |
| Aug 28, 2023 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 2K | $1.26 | $2K |
| Aug 28, 2023 | Keutzer Timothy | Chief Development Officer | Sell(S) | 2K | $1.26 | $2K |
| Aug 1, 2023 | Shukla Sath | CEO and President, Director | Grant(A) | 266K | — | $0 |
| Jun 12, 2023 | Hamed Kamal | Chief Medical Officer | Grant(A) | 140K | — | $0 |
| Feb 3, 2023 | Mahadevia Ankit | CEO and President, Director | Sell(S) | 12K | $1.81 | $22K |
| Feb 2, 2023 | Shukla Sath | Chief Financial Officer | Sell(S) | 10K | $1.83 | $17K |
| Feb 2, 2023 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 3K | $1.86 | $6K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Spero Therapeutics, Inc., SEC CIK 0001701108. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SPRO and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SPRO